Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription Articles published in Ann Intern Med Retrieve available abstracts of 47 articles: HTML format

Single Articles

March 2026
1. QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
   Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05485.
   PubMed     Abstract available
   
   
   
2. MOSER ITK, Dobrescu AI, Sommer I, Goeschl S, et al
   Efficacy, Comparative Effectiveness, and Harm of Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05536.
   PubMed     Abstract available
   
   
   
3. SACKS HS
   In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia in those with CKD.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-26-00324.
   PubMed     Abstract available
   
   
   
4. ANAND R, Glatt AE
   In healthy adults, a modified RNA vs. inactivated influenza vaccine reduced laboratory-confirmed influenza-like illness at >/=14 d.
   Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05681.
   PubMed     Abstract available
   
   
   February 2026
5. QASEEM A, Obley AJ, Harrod CS, Wilt TJ, et al
   COVID-19 Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
   PubMed     Abstract available
   
   
   
6. 
   Annals Video Summary - COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised.
   Ann Intern Med. 2026 Feb 24:e2600306VS. doi: 10.7326/ANNALS-26-00306.
   PubMed    
   
   
   
7. 
   Summary for Patients: COVID-19 Vaccines for 2025-2026.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05026.
   PubMed    
   
   
   
8. DOBRESCU A, Pinte L, Sharifan A, Gadinger A, et al
   Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
   Ann Intern Med. 2026 Feb 24. doi: 10.7326/ANNALS-25-05044.
   PubMed     Abstract available
   
   
   
9. PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
   Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
   Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
   PubMed     Abstract available
   
   
   
10. 
    Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
    PubMed    
    
    
    
11. STENSBALLE LG
    Context Matters: Comparing the United States and Denmark in Vaccine-Preventable Disease Risk.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-26-00249.
    PubMed    
    
    
    
12. WENTZENSEN N, Egemen D
    Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
    PubMed    
    
    
    January 2026
13. TERAN-PLASENCIA JM, Kalil AC
    In adults hospitalized with acute HF, predischarge influenza vaccination reduced a composite of mortality or readmission at 1 y.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-04799.
    PubMed     Abstract available
    
    
    
14. TONG SYC, Gibney KB
    In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05209.
    PubMed     Abstract available
    
    
    
15. SACKS HS
    In older adults, RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease vs. no vaccine.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05113.
    PubMed     Abstract available
    
    
    November 2025
16. QASEEM A, Wilt TJ, Harrod CS, Obley AJ, et al
    Influenza Vaccines for 2025-2026 in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians.
    Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04056.
    PubMed     Abstract available
    
    
    
17. 
    Web Exclusive. Annals Video Summary - Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2025 Nov 18:e2504658VS. doi: 10.7326/ANNALS-25-04658.
    PubMed    
    
    
    
18. DOBRESCU AI, Sharifan A, Sommer I, Neubauer-Bruckner CIA, et al
    Comparative Effectiveness and Harm of Seasonal Influenza Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.
    Ann Intern Med. 2025 Nov 18. doi: 10.7326/ANNALS-25-04028.
    PubMed     Abstract available
    
    
    
19. SHABBIR R, Shabbir Z
    A Reminder in Every Story: The Cost of Vaccine Hesitancy.
    Ann Intern Med. 2025 Nov 11. doi: 10.7326/ANNALS-25-02508.
    PubMed    
    
    
    
20. BOEDER N, Butler K
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2025;178:1673.
    PubMed    
    
    
    
21. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2025;178:1674-1675.
    PubMed    
    
    
    October 2025
22. VIELOT NA, Jonsson Funk M, Sturmer T, Fix J, et al
    Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine.
    Ann Intern Med. 2025 Oct 14. doi: 10.7326/ANNALS-24-02409.
    PubMed     Abstract available
    
    
    September 2025
23. ANDREWS RA, Erickson SM, Goldman JM, Moyer DV, et al
    Deja Flu All Over Again: The Risk for Overwhelm of the U.S. Health Care System by Vaccine-Preventable and Modifiable Diseases.
    Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-25-03999.
    PubMed    
    
    
    
24. LAINE C, Turner BJ, Qaseem A, Moyer DV, et al
    Vaccines: Decision Making Amid Conflicting Recommendations.
    Ann Intern Med. 2025 Sep 16. doi: 10.7326/ANNALS-25-04054.
    PubMed    
    
    
    July 2025
25. KOBAYASHI M, Loehr J, Caine VA, Cohen AL, et al
    New Pneumococcal Vaccine Recommendation for U.S. Adults Aged 50 Years and Older-Promise and Challenges.
    Ann Intern Med. 2025 Jul 22. doi: 10.7326/ANNALS-25-01178.
    PubMed    
    
    
    
26. 
    Correction: Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood.
    Ann Intern Med. 2025 Jul 17. doi: 10.7326/ANNALS-25-03233.
    PubMed    
    
    
    
27. 
    Summary for Patients: Aluminum in Vaccines and the Risk for Childhood Disease.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    PubMed    
    
    
    
28. ANDERSSON NW, Bech Svalgaard I, Hoffmann SS, Hviid A, et al
    Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood : A Nationwide Cohort Study.
    Ann Intern Med. 2025 Jul 15. doi: 10.7326/ANNALS-25-00997.
    PubMed     Abstract available
    
    
    June 2025
29. GOLDMAN JM, Fryhofer SA
    Preserving Scientific Integrity in Vaccine Policy: The Role of, and Risk to, the CDC's Advisory Committee on Immunization Practices.
    Ann Intern Med. 2025 Jun 24. doi: 10.7326/ANNALS-25-02806.
    PubMed    
    
    
    May 2025
30. JACOBS JW, Booth GS, Lewis-Newby M, Saifee NH, et al
    Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025.
    Ann Intern Med. 2025 May 13. doi: 10.7326/ANNALS-25-00815.
    PubMed     Abstract available
    
    
    April 2025
31. BLUMENTHAL KG, Phillips EJ
    Chronic Urticaria Following HIV mRNA Vaccines: A Challenging Signal in Need of Mechanistic Insight.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-25-01102.
    PubMed    
    
    
    
32. RIDDLER SA, Moodie Z, Clark J, Yen C, et al
    High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701.
    PubMed     Abstract available
    
    
    
33. BILINSKI A, Emanuel N, Ciaranello A
    Sins of Omission: Model-Based Estimates of the Health Effects of Excluding Pregnant Participants From Randomized Controlled Trials.
    Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-00689.
    PubMed     Abstract available
    
    
    
34. DACSO CC
    Coadministration of RSV + influenza or COVID-19 vaccines was noninferior to separate administration for immune responses in adults aged >/=50 y.
    Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00904.
    PubMed     Abstract available
    
    
    February 2025
35. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015.
    PubMed     Abstract available
    
    
    December 2024
36. VASSILOPOULOS S, Mylonakis E
    After COVID-19 diagnosis, risk for incident type 2 diabetes was elevated for up to 2 y.
    Ann Intern Med. 2024 Dec 3. doi: 10.7326/ANNALS-24-02887.
    PubMed     Abstract available
    
    
    November 2024
37. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
    PubMed     Abstract available
    
    
    July 2024
38. KAUFFMAN RP
    mRNA COVID-19 vaccination during pregnancy was not linked to increased adverse neonatal outcomes.
    Ann Intern Med. 2024 Jul 2. doi: 10.7326/ANNALS-24-00621.
    PubMed     Abstract available
    
    
    
39. FUJIEDA T, Tanimoto T
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990-991.
    PubMed    
    
    
    
40. SCHATTNER A
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:990.
    PubMed    
    
    
    
41. TENFORDE MW, Dawood FS
    Communicating the Value of Influenza Vaccines to Patients.
    Ann Intern Med. 2024;177:991.
    PubMed    
    
    
    June 2024
42. DUTCHER EG, Epel ES, Mason AE, Hecht FM, et al
    COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response : A Prospective Cohort Study.
    Ann Intern Med. 2024 Jun 11. doi: 10.7326/M23-2956.
    PubMed     Abstract available
    
    
    May 2024
43. 
    Notice of Retraction: Measles, Mumps, Rubella Vaccination and Autism.
    Ann Intern Med. 2024 May 21. doi: 10.7326/ANNALS-24-00530.
    PubMed    
    
    
    April 2024
44. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    PubMed     Abstract available
    
    
    March 2024
45. WELLS CR, Pandey A, Moghadas SM, Fitzpatrick MC, et al
    Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-2451.
    PubMed     Abstract available
    
    
    
46. HUITS R, Grubaugh ND, Libman M, Hamer DH, et al
    Resurgence of Dengue in the Era of Genomic Surveillance and Vaccines.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M24-0496.
    PubMed    
    
    
    
47. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation Trial.
    Ann Intern Med. 2024 Mar 19. doi: 10.7326/M23-2638.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum